CAS 1564265-96-8

(1R,3S,5R,2’S)-Saxagliptin

CAS : 1564265-96-8

Formule : C₁₈H₂₅N₃O₂

Masse moléculaire : 315.42

Ref: 4Z-S-328

(2S,2S’,trans)-Saxagliptin

Produit contrôlé

CAS : 1564265-96-8

Formule : C₁₈H₂₅N₃O₂

Couleur et forme : Neat

Masse moléculaire : 315.41

Ref: TR-S143490

(2S,2S,Trans)-saxagliptin

CAS : 1564265-96-8

(2S,2S,Trans)-saxagliptin is a drug product that has been developed as an oral anti-diabetic agent. It is a synthetic compound with the chemical name of (2S,2S,Trans)-4-[(1R)-1-[[(3Z)-3-(dimethylamino)-1-[(4-methylphenyl)sulfonyl]propanoyl]amino]-2-methylpropyl]-N-[4-(6-methoxy-3-pyridinyl)benzoyl]glycine. The synthesis of this drug is based on the natural amino acid sequence of the human insulin molecule. (2S,2S,Trans)-saxagliptin has been shown to be metabolized in vivo through hydroxylation and glucuronidation pathways and to have a half life of approximately 10 hours in humans. This drug product is intended for research and development purposes only

Formule : C₁₈H₂₅N₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 315.40 g/mol

Ref: 3D-PMC26596

(2S,2S’,Trans)-Saxagliptin

CAS : 1564265-96-8

Formule : C₁₈H₂₅N₃O₂

Masse moléculaire : 315.42

Ref: ST-EA-CP-S19044